nodes	percent_of_prediction	percent_of_DWPC	metapath
Midazolam—ABCB1—Levothyroxine—hypothyroidism	0.0721	0.28	CbGbCtD
Midazolam—ABCB1—Liothyronine—hypothyroidism	0.0721	0.28	CbGbCtD
Midazolam—ABCB1—Liotrix—hypothyroidism	0.0704	0.273	CbGbCtD
Midazolam—CYP3A4—Levothyroxine—hypothyroidism	0.0432	0.168	CbGbCtD
Midazolam—Gagging—Dextrothyroxine—hypothyroidism	0.0378	0.0783	CcSEcCtD
Midazolam—Gagging—Levothyroxine—hypothyroidism	0.0378	0.0783	CcSEcCtD
Midazolam—Cardio-respiratory arrest—Liothyronine—hypothyroidism	0.0333	0.069	CcSEcCtD
Midazolam—Gagging—Liotrix—hypothyroidism	0.0278	0.0576	CcSEcCtD
Midazolam—Retching—Dextrothyroxine—hypothyroidism	0.0171	0.0354	CcSEcCtD
Midazolam—Retching—Levothyroxine—hypothyroidism	0.0171	0.0354	CcSEcCtD
Midazolam—Warmth—Liotrix—hypothyroidism	0.0135	0.028	CcSEcCtD
Midazolam—GABRR3—nerve—hypothyroidism	0.0132	0.0659	CbGeAlD
Midazolam—GABRQ—nerve—hypothyroidism	0.0132	0.0659	CbGeAlD
Midazolam—Retching—Liotrix—hypothyroidism	0.0126	0.0261	CcSEcCtD
Midazolam—Muscle twitching—Liothyronine—hypothyroidism	0.0121	0.0251	CcSEcCtD
Midazolam—Cardio-respiratory arrest—Liotrix—hypothyroidism	0.012	0.0249	CcSEcCtD
Midazolam—GABRR2—nerve—hypothyroidism	0.0114	0.0571	CbGeAlD
Midazolam—GABRR1—nerve—hypothyroidism	0.011	0.055	CbGeAlD
Midazolam—Phlebitis—Liothyronine—hypothyroidism	0.01	0.0208	CcSEcCtD
Midazolam—Wheezing—Dextrothyroxine—hypothyroidism	0.00567	0.0118	CcSEcCtD
Midazolam—Wheezing—Levothyroxine—hypothyroidism	0.00567	0.0118	CcSEcCtD
Midazolam—Feeling hot—Liotrix—hypothyroidism	0.00547	0.0113	CcSEcCtD
Midazolam—CYP4B1—adrenal cortex—hypothyroidism	0.00544	0.0272	CbGeAlD
Midazolam—CYP4B1—heart—hypothyroidism	0.00526	0.0264	CbGeAlD
Midazolam—Hyperkinesia—Levothyroxine—hypothyroidism	0.00509	0.0106	CcSEcCtD
Midazolam—Hyperkinesia—Dextrothyroxine—hypothyroidism	0.00509	0.0106	CcSEcCtD
Midazolam—Tenderness—Liotrix—hypothyroidism	0.00492	0.0102	CcSEcCtD
Midazolam—CYP2E1—urine—hypothyroidism	0.00476	0.0238	CbGeAlD
Midazolam—Disorientation—Dextrothyroxine—hypothyroidism	0.00474	0.00982	CcSEcCtD
Midazolam—Disorientation—Levothyroxine—hypothyroidism	0.00474	0.00982	CcSEcCtD
Midazolam—CYP4B1—pituitary gland—hypothyroidism	0.0044	0.022	CbGeAlD
Midazolam—Muscle twitching—Liotrix—hypothyroidism	0.00437	0.00907	CcSEcCtD
Midazolam—Cardiac failure—Levothyroxine—hypothyroidism	0.00434	0.00901	CcSEcCtD
Midazolam—Cardiac failure—Dextrothyroxine—hypothyroidism	0.00434	0.00901	CcSEcCtD
Midazolam—Affect lability—Levothyroxine—hypothyroidism	0.00417	0.00865	CcSEcCtD
Midazolam—Affect lability—Dextrothyroxine—hypothyroidism	0.00417	0.00865	CcSEcCtD
Midazolam—Wheezing—Liotrix—hypothyroidism	0.00417	0.00865	CcSEcCtD
Midazolam—Tachycardia—Liothyronine—hypothyroidism	0.00414	0.00858	CcSEcCtD
Midazolam—Irritability—Dextrothyroxine—hypothyroidism	0.00405	0.00839	CcSEcCtD
Midazolam—Irritability—Levothyroxine—hypothyroidism	0.00405	0.00839	CcSEcCtD
Midazolam—Cardiac arrest—Levothyroxine—hypothyroidism	0.00403	0.00836	CcSEcCtD
Midazolam—Cardiac arrest—Dextrothyroxine—hypothyroidism	0.00403	0.00836	CcSEcCtD
Midazolam—Mood swings—Dextrothyroxine—hypothyroidism	0.00402	0.00833	CcSEcCtD
Midazolam—Mood swings—Levothyroxine—hypothyroidism	0.00402	0.00833	CcSEcCtD
Midazolam—UGT1A4—blood—hypothyroidism	0.00398	0.0199	CbGeAlD
Midazolam—Hypotension—Liothyronine—hypothyroidism	0.00396	0.00822	CcSEcCtD
Midazolam—CYP4B1—adrenal gland—hypothyroidism	0.00393	0.0197	CbGeAlD
Midazolam—Lightheadedness—Liotrix—hypothyroidism	0.00384	0.00797	CcSEcCtD
Midazolam—CYP3A4—urine—hypothyroidism	0.00383	0.0192	CbGeAlD
Midazolam—CYP4B1—thyroid gland—hypothyroidism	0.00379	0.019	CbGeAlD
Midazolam—Hyperkinesia—Liotrix—hypothyroidism	0.00375	0.00777	CcSEcCtD
Midazolam—Muscular weakness—Dextrothyroxine—hypothyroidism	0.00374	0.00775	CcSEcCtD
Midazolam—Muscular weakness—Levothyroxine—hypothyroidism	0.00374	0.00775	CcSEcCtD
Midazolam—CYP4B1—female gonad—hypothyroidism	0.00366	0.0183	CbGeAlD
Midazolam—Phlebitis—Liotrix—hypothyroidism	0.00362	0.0075	CcSEcCtD
Midazolam—GABRG3—pituitary gland—hypothyroidism	0.00357	0.0179	CbGeAlD
Midazolam—Swelling—Liotrix—hypothyroidism	0.00353	0.00733	CcSEcCtD
Midazolam—Disorientation—Liotrix—hypothyroidism	0.00349	0.00723	CcSEcCtD
Midazolam—CYP4B1—testis—hypothyroidism	0.00325	0.0163	CbGeAlD
Midazolam—Cardiac failure—Liotrix—hypothyroidism	0.00319	0.00662	CcSEcCtD
Midazolam—UGT1A4—liver—hypothyroidism	0.00311	0.0156	CbGeAlD
Midazolam—Affect lability—Liotrix—hypothyroidism	0.00307	0.00636	CcSEcCtD
Midazolam—CYP4B1—cerebellum—hypothyroidism	0.003	0.015	CbGeAlD
Midazolam—GABRA4—heart—hypothyroidism	0.00298	0.0149	CbGeAlD
Midazolam—Irritability—Liotrix—hypothyroidism	0.00298	0.00617	CcSEcCtD
Midazolam—Cardiac arrest—Liotrix—hypothyroidism	0.00296	0.00615	CcSEcCtD
Midazolam—Mood swings—Liotrix—hypothyroidism	0.00295	0.00612	CcSEcCtD
Midazolam—GABRB1—pituitary gland—hypothyroidism	0.00276	0.0138	CbGeAlD
Midazolam—Muscular weakness—Liotrix—hypothyroidism	0.00275	0.0057	CcSEcCtD
Midazolam—Bronchospasm—Liotrix—hypothyroidism	0.00265	0.0055	CcSEcCtD
Midazolam—GABRG3—testis—hypothyroidism	0.00264	0.0132	CbGeAlD
Midazolam—GABRR1—testis—hypothyroidism	0.00252	0.0126	CbGeAlD
Midazolam—Tension—Dextrothyroxine—hypothyroidism	0.0025	0.00519	CcSEcCtD
Midazolam—Tension—Levothyroxine—hypothyroidism	0.0025	0.00519	CcSEcCtD
Midazolam—GABRA4—pituitary gland—hypothyroidism	0.00249	0.0125	CbGeAlD
Midazolam—Nervousness—Levothyroxine—hypothyroidism	0.00248	0.00514	CcSEcCtD
Midazolam—Nervousness—Dextrothyroxine—hypothyroidism	0.00248	0.00514	CcSEcCtD
Midazolam—GABRP—pituitary gland—hypothyroidism	0.00248	0.0124	CbGeAlD
Midazolam—GABRR2—cerebellum—hypothyroidism	0.00241	0.0121	CbGeAlD
Midazolam—Tremor—Dextrothyroxine—hypothyroidism	0.00239	0.00496	CcSEcCtD
Midazolam—Tremor—Levothyroxine—hypothyroidism	0.00239	0.00496	CcSEcCtD
Midazolam—Agitation—Dextrothyroxine—hypothyroidism	0.00235	0.00486	CcSEcCtD
Midazolam—Agitation—Levothyroxine—hypothyroidism	0.00235	0.00486	CcSEcCtD
Midazolam—GABRE—heart—hypothyroidism	0.00226	0.0113	CbGeAlD
Midazolam—GABRA3—thyroid gland—hypothyroidism	0.00221	0.011	CbGeAlD
Midazolam—GABRD—testis—hypothyroidism	0.00219	0.011	CbGeAlD
Midazolam—CYP3A7—liver—hypothyroidism	0.00217	0.0109	CbGeAlD
Midazolam—Anxiety—Dextrothyroxine—hypothyroidism	0.00217	0.00449	CcSEcCtD
Midazolam—Anxiety—Levothyroxine—hypothyroidism	0.00217	0.00449	CcSEcCtD
Midazolam—Confusional state—Levothyroxine—hypothyroidism	0.0021	0.00436	CcSEcCtD
Midazolam—Confusional state—Dextrothyroxine—hypothyroidism	0.0021	0.00436	CcSEcCtD
Midazolam—GABRG2—pituitary gland—hypothyroidism	0.00209	0.0104	CbGeAlD
Midazolam—Shock—Dextrothyroxine—hypothyroidism	0.00205	0.00425	CcSEcCtD
Midazolam—Shock—Levothyroxine—hypothyroidism	0.00205	0.00425	CcSEcCtD
Midazolam—Tachycardia—Levothyroxine—hypothyroidism	0.00203	0.00422	CcSEcCtD
Midazolam—Tachycardia—Dextrothyroxine—hypothyroidism	0.00203	0.00422	CcSEcCtD
Midazolam—GABRA5—testis—hypothyroidism	0.00203	0.0102	CbGeAlD
Midazolam—GABRD—cerebellum—hypothyroidism	0.00202	0.0101	CbGeAlD
Midazolam—GABRG1—cerebellum—hypothyroidism	0.00194	0.00974	CbGeAlD
Midazolam—GABRA6—cerebellum—hypothyroidism	0.00193	0.00968	CbGeAlD
Midazolam—GABRB3—heart—hypothyroidism	0.00192	0.0096	CbGeAlD
Midazolam—GABRA3—testis—hypothyroidism	0.00189	0.00947	CbGeAlD
Midazolam—GABRE—pituitary gland—hypothyroidism	0.00189	0.00946	CbGeAlD
Midazolam—GABRB1—cerebellum—hypothyroidism	0.00189	0.00944	CbGeAlD
Midazolam—Dyspnoea—Dextrothyroxine—hypothyroidism	0.00186	0.00385	CcSEcCtD
Midazolam—Dyspnoea—Levothyroxine—hypothyroidism	0.00186	0.00385	CcSEcCtD
Midazolam—CYP3A7-CYP3A51P—liver—hypothyroidism	0.00184	0.00923	CbGeAlD
Midazolam—Tension—Liotrix—hypothyroidism	0.00184	0.00382	CcSEcCtD
Midazolam—Nervousness—Liotrix—hypothyroidism	0.00182	0.00378	CcSEcCtD
Midazolam—Fatigue—Dextrothyroxine—hypothyroidism	0.0018	0.00372	CcSEcCtD
Midazolam—Fatigue—Levothyroxine—hypothyroidism	0.0018	0.00372	CcSEcCtD
Midazolam—Vision blurred—Liotrix—hypothyroidism	0.00177	0.00367	CcSEcCtD
Midazolam—SLC22A1—Amine compound SLC transporters—SLC5A7—hypothyroidism	0.00177	0.0293	CbGpPWpGaD
Midazolam—Tremor—Liotrix—hypothyroidism	0.00176	0.00365	CcSEcCtD
Midazolam—Agitation—Liotrix—hypothyroidism	0.00173	0.00358	CcSEcCtD
Midazolam—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.00172	0.00356	CcSEcCtD
Midazolam—Feeling abnormal—Levothyroxine—hypothyroidism	0.00172	0.00356	CcSEcCtD
Midazolam—GABRA2—adrenal gland—hypothyroidism	0.0017	0.00852	CbGeAlD
Midazolam—GABRA4—cerebellum—hypothyroidism	0.0017	0.00852	CbGeAlD
Midazolam—GABRE—adrenal gland—hypothyroidism	0.00169	0.00845	CbGeAlD
Midazolam—Syncope—Liotrix—hypothyroidism	0.00168	0.00349	CcSEcCtD
Midazolam—Urticaria—Dextrothyroxine—hypothyroidism	0.00166	0.00343	CcSEcCtD
Midazolam—Urticaria—Levothyroxine—hypothyroidism	0.00166	0.00343	CcSEcCtD
Midazolam—GABRB3—gonad—hypothyroidism	0.00164	0.00822	CbGeAlD
Midazolam—GABRE—thyroid gland—hypothyroidism	0.00163	0.00816	CbGeAlD
Midazolam—SLC22A1—blood—hypothyroidism	0.00161	0.00805	CbGeAlD
Midazolam—GABRB3—pituitary gland—hypothyroidism	0.0016	0.00802	CbGeAlD
Midazolam—Anxiety—Liotrix—hypothyroidism	0.00159	0.0033	CcSEcCtD
Midazolam—GABRE—female gonad—hypothyroidism	0.00157	0.00788	CbGeAlD
Midazolam—Confusional state—Liotrix—hypothyroidism	0.00155	0.0032	CcSEcCtD
Midazolam—GABRB2—testis—hypothyroidism	0.00154	0.00772	CbGeAlD
Midazolam—Anaphylactic shock—Liotrix—hypothyroidism	0.00153	0.00318	CcSEcCtD
Midazolam—Shock—Liotrix—hypothyroidism	0.00151	0.00313	CcSEcCtD
Midazolam—Tachycardia—Liotrix—hypothyroidism	0.0015	0.0031	CcSEcCtD
Midazolam—Asthenia—Levothyroxine—hypothyroidism	0.00149	0.0031	CcSEcCtD
Midazolam—Asthenia—Dextrothyroxine—hypothyroidism	0.00149	0.0031	CcSEcCtD
Midazolam—Pruritus—Dextrothyroxine—hypothyroidism	0.00147	0.00306	CcSEcCtD
Midazolam—Pruritus—Levothyroxine—hypothyroidism	0.00147	0.00306	CcSEcCtD
Midazolam—Hypotension—Liotrix—hypothyroidism	0.00143	0.00297	CcSEcCtD
Midazolam—GABRB2—cerebellum—hypothyroidism	0.00142	0.00713	CbGeAlD
Midazolam—GABRG2—cerebellum—hypothyroidism	0.00142	0.00713	CbGeAlD
Midazolam—GABRE—testis—hypothyroidism	0.0014	0.00699	CbGeAlD
Midazolam—GABRB3—thyroid gland—hypothyroidism	0.00138	0.00691	CbGeAlD
Midazolam—Paraesthesia—Liotrix—hypothyroidism	0.00138	0.00285	CcSEcCtD
Midazolam—Dyspnoea—Liotrix—hypothyroidism	0.00137	0.00283	CcSEcCtD
Midazolam—SLC22A1—Neurotransmitter Release Cycle—SLC5A7—hypothyroidism	0.00135	0.0224	CbGpPWpGaD
Midazolam—CYP2B6—adrenal cortex—hypothyroidism	0.00134	0.00673	CbGeAlD
Midazolam—Vomiting—Dextrothyroxine—hypothyroidism	0.00132	0.00275	CcSEcCtD
Midazolam—Vomiting—Levothyroxine—hypothyroidism	0.00132	0.00275	CcSEcCtD
Midazolam—Fatigue—Liotrix—hypothyroidism	0.00132	0.00274	CcSEcCtD
Midazolam—Rash—Dextrothyroxine—hypothyroidism	0.00131	0.00272	CcSEcCtD
Midazolam—Rash—Levothyroxine—hypothyroidism	0.00131	0.00272	CcSEcCtD
Midazolam—Dermatitis—Levothyroxine—hypothyroidism	0.00131	0.00272	CcSEcCtD
Midazolam—Dermatitis—Dextrothyroxine—hypothyroidism	0.00131	0.00272	CcSEcCtD
Midazolam—Constipation—Liotrix—hypothyroidism	0.00131	0.00272	CcSEcCtD
Midazolam—Headache—Levothyroxine—hypothyroidism	0.00131	0.00271	CcSEcCtD
Midazolam—Headache—Dextrothyroxine—hypothyroidism	0.00131	0.00271	CcSEcCtD
Midazolam—GABRA2—cerebellum—hypothyroidism	0.0013	0.00651	CbGeAlD
Midazolam—CYP2B6—heart—hypothyroidism	0.0013	0.00651	CbGeAlD
Midazolam—Feeling abnormal—Liotrix—hypothyroidism	0.00126	0.00262	CcSEcCtD
Midazolam—SLC22A1—liver—hypothyroidism	0.00126	0.00629	CbGeAlD
Midazolam—GABRA1—cerebellum—hypothyroidism	0.00126	0.00629	CbGeAlD
Midazolam—Nausea—Dextrothyroxine—hypothyroidism	0.00124	0.00257	CcSEcCtD
Midazolam—Nausea—Levothyroxine—hypothyroidism	0.00124	0.00257	CcSEcCtD
Midazolam—CYP2B6—cardiovascular system—hypothyroidism	0.00123	0.00614	CbGeAlD
Midazolam—Urticaria—Liotrix—hypothyroidism	0.00122	0.00252	CcSEcCtD
Midazolam—GABRB3—testis—hypothyroidism	0.00118	0.00593	CbGeAlD
Midazolam—CYP2E1—cardiovascular system—hypothyroidism	0.00115	0.00576	CbGeAlD
Midazolam—Hypersensitivity—Liotrix—hypothyroidism	0.00113	0.00234	CcSEcCtD
Midazolam—GABRB3—liver—hypothyroidism	0.00112	0.0056	CbGeAlD
Midazolam—CYP2B6—gonad—hypothyroidism	0.00111	0.00557	CbGeAlD
Midazolam—UGT1A4—NRF2 pathway—SLC5A7—hypothyroidism	0.00111	0.0184	CbGpPWpGaD
Midazolam—Asthenia—Liotrix—hypothyroidism	0.0011	0.00228	CcSEcCtD
Midazolam—GABRB3—cerebellum—hypothyroidism	0.00109	0.00547	CbGeAlD
Midazolam—Pruritus—Liotrix—hypothyroidism	0.00108	0.00225	CcSEcCtD
Midazolam—Dizziness—Liotrix—hypothyroidism	0.00101	0.0021	CcSEcCtD
Midazolam—CYP3A5—blood—hypothyroidism	0.000976	0.00489	CbGeAlD
Midazolam—Vomiting—Liotrix—hypothyroidism	0.000974	0.00202	CcSEcCtD
Midazolam—CYP2B6—adrenal gland—hypothyroidism	0.00097	0.00486	CbGeAlD
Midazolam—CYP2B6—blood—hypothyroidism	0.00097	0.00486	CbGeAlD
Midazolam—Rash—Liotrix—hypothyroidism	0.000966	0.002	CcSEcCtD
Midazolam—Dermatitis—Liotrix—hypothyroidism	0.000965	0.002	CcSEcCtD
Midazolam—Headache—Liotrix—hypothyroidism	0.00096	0.00199	CcSEcCtD
Midazolam—CYP2E1—adrenal gland—hypothyroidism	0.00091	0.00456	CbGeAlD
Midazolam—Nausea—Liotrix—hypothyroidism	0.00091	0.00189	CcSEcCtD
Midazolam—CYP2E1—blood—hypothyroidism	0.00091	0.00456	CbGeAlD
Midazolam—CYP3A5—female gonad—hypothyroidism	0.00091	0.00456	CbGeAlD
Midazolam—CYP2E1—thyroid gland—hypothyroidism	0.000878	0.0044	CbGeAlD
Midazolam—GABRR1—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000856	0.0142	CbGpPWpGaD
Midazolam—GABRR2—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000816	0.0136	CbGpPWpGaD
Midazolam—GABRQ—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000816	0.0136	CbGpPWpGaD
Midazolam—CYP2B6—testis—hypothyroidism	0.000802	0.00402	CbGeAlD
Midazolam—CYP3A5—liver—hypothyroidism	0.000763	0.00382	CbGeAlD
Midazolam—CYP2B6—liver—hypothyroidism	0.000758	0.0038	CbGeAlD
Midazolam—CYP4B1—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000754	0.0125	CbGpPWpGaD
Midazolam—CYP2E1—testis—hypothyroidism	0.000753	0.00377	CbGeAlD
Midazolam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000733	0.0122	CbGpPWpGaD
Midazolam—CYP3A4—blood—hypothyroidism	0.000732	0.00367	CbGeAlD
Midazolam—ABCB1—adrenal cortex—hypothyroidism	0.000718	0.0036	CbGeAlD
Midazolam—CYP2E1—liver—hypothyroidism	0.000712	0.00356	CbGeAlD
Midazolam—GABRQ—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.0007	0.0116	CbGpPWpGaD
Midazolam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.0007	0.0116	CbGpPWpGaD
Midazolam—CYP2E1—cerebellum—hypothyroidism	0.000695	0.00348	CbGeAlD
Midazolam—ABCB1—heart—hypothyroidism	0.000695	0.00348	CbGeAlD
Midazolam—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A7—hypothyroidism	0.000691	0.0115	CbGpPWpGaD
Midazolam—GABRA1—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.000677	0.0112	CbGpPWpGaD
Midazolam—GABRG3—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000672	0.0112	CbGpPWpGaD
Midazolam—GABRB1—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000662	0.011	CbGpPWpGaD
Midazolam—GABRR1—Neuronal System—SLC5A7—hypothyroidism	0.000656	0.0109	CbGpPWpGaD
Midazolam—ABCB1—cardiovascular system—hypothyroidism	0.000655	0.00328	CbGeAlD
Midazolam—GABRA6—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000626	0.0104	CbGpPWpGaD
Midazolam—GABRR2—Neuronal System—SLC5A7—hypothyroidism	0.000625	0.0104	CbGpPWpGaD
Midazolam—GABRQ—Neuronal System—SLC5A7—hypothyroidism	0.000625	0.0104	CbGpPWpGaD
Midazolam—GABRA4—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000619	0.0103	CbGpPWpGaD
Midazolam—CYP4B1—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000611	0.0102	CbGpPWpGaD
Midazolam—ABCB1—gonad—hypothyroidism	0.000595	0.00298	CbGeAlD
Midazolam—ABCB1—pituitary gland—hypothyroidism	0.00058	0.00291	CbGeAlD
Midazolam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000576	0.00957	CbGpPWpGaD
Midazolam—CYP3A4—liver—hypothyroidism	0.000573	0.00287	CbGeAlD
Midazolam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000568	0.00943	CbGpPWpGaD
Midazolam—GABRB2—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000566	0.0094	CbGpPWpGaD
Midazolam—GABRR1—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000551	0.00916	CbGpPWpGaD
Midazolam—GABRA5—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00055	0.00913	CbGpPWpGaD
Midazolam—GABRA3—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00054	0.00897	CbGpPWpGaD
Midazolam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000537	0.00892	CbGpPWpGaD
Midazolam—GABRA2—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00053	0.00881	CbGpPWpGaD
Midazolam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00053	0.00881	CbGpPWpGaD
Midazolam—GABRB3—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000527	0.00876	CbGpPWpGaD
Midazolam—GABRQ—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000526	0.00874	CbGpPWpGaD
Midazolam—GABRR2—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000526	0.00874	CbGpPWpGaD
Midazolam—ABCB1—adrenal gland—hypothyroidism	0.000518	0.0026	CbGeAlD
Midazolam—ABCB1—blood—hypothyroidism	0.000518	0.0026	CbGeAlD
Midazolam—GABRG2—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000517	0.0086	CbGpPWpGaD
Midazolam—GABRG3—Neuronal System—SLC5A7—hypothyroidism	0.000515	0.00856	CbGpPWpGaD
Midazolam—GABRB1—Neuronal System—SLC5A7—hypothyroidism	0.000507	0.00843	CbGpPWpGaD
Midazolam—ABCB1—thyroid gland—hypothyroidism	0.0005	0.00251	CbGeAlD
Midazolam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000485	0.00806	CbGpPWpGaD
Midazolam—ABCB1—female gonad—hypothyroidism	0.000483	0.00242	CbGeAlD
Midazolam—GABRA6—Neuronal System—SLC5A7—hypothyroidism	0.00048	0.00798	CbGpPWpGaD
Midazolam—GABRA4—Neuronal System—SLC5A7—hypothyroidism	0.000474	0.00788	CbGpPWpGaD
Midazolam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000471	0.00783	CbGpPWpGaD
Midazolam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000463	0.00769	CbGpPWpGaD
Midazolam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000455	0.00756	CbGpPWpGaD
Midazolam—GABRA1—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000452	0.00752	CbGpPWpGaD
Midazolam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000452	0.00751	CbGpPWpGaD
Midazolam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000444	0.00737	CbGpPWpGaD
Midazolam—UGT1A4—NRF2 pathway—SLC5A5—hypothyroidism	0.000443	0.00736	CbGpPWpGaD
Midazolam—GABRA1—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.000436	0.00725	CbGpPWpGaD
Midazolam—GABRB2—Neuronal System—SLC5A7—hypothyroidism	0.000433	0.0072	CbGpPWpGaD
Midazolam—GABRG3—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000433	0.0072	CbGpPWpGaD
Midazolam—ABCB1—testis—hypothyroidism	0.000429	0.00215	CbGeAlD
Midazolam—GABRB1—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000427	0.00709	CbGpPWpGaD
Midazolam—GABRR1—Neuronal System—NEFL—hypothyroidism	0.000422	0.00702	CbGpPWpGaD
Midazolam—GABRA5—Neuronal System—SLC5A7—hypothyroidism	0.000421	0.007	CbGpPWpGaD
Midazolam—GABRA3—Neuronal System—SLC5A7—hypothyroidism	0.000414	0.00687	CbGpPWpGaD
Midazolam—GABRA2—Neuronal System—SLC5A7—hypothyroidism	0.000406	0.00675	CbGpPWpGaD
Midazolam—ABCB1—liver—hypothyroidism	0.000405	0.00203	CbGeAlD
Midazolam—GABRB3—Neuronal System—SLC5A7—hypothyroidism	0.000404	0.00671	CbGpPWpGaD
Midazolam—GABRA6—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000404	0.00671	CbGpPWpGaD
Midazolam—GABRQ—Neuronal System—NEFL—hypothyroidism	0.000403	0.0067	CbGpPWpGaD
Midazolam—GABRR2—Neuronal System—NEFL—hypothyroidism	0.000403	0.0067	CbGpPWpGaD
Midazolam—GABRA4—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000399	0.00662	CbGpPWpGaD
Midazolam—GABRG2—Neuronal System—SLC5A7—hypothyroidism	0.000396	0.00659	CbGpPWpGaD
Midazolam—ABCB1—cerebellum—hypothyroidism	0.000396	0.00198	CbGeAlD
Midazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000388	0.00644	CbGpPWpGaD
Midazolam—SLC22A1—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000387	0.00643	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—IYD—hypothyroidism	0.000383	0.00637	CbGpPWpGaD
Midazolam—GABRB2—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000365	0.00606	CbGpPWpGaD
Midazolam—GABRA5—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000354	0.00589	CbGpPWpGaD
Midazolam—GABRR1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000352	0.00586	CbGpPWpGaD
Midazolam—GABRA3—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000348	0.00578	CbGpPWpGaD
Midazolam—GABRA1—Neuronal System—SLC5A7—hypothyroidism	0.000347	0.00576	CbGpPWpGaD
Midazolam—GABRA2—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000342	0.00568	CbGpPWpGaD
Midazolam—GABRB3—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00034	0.00564	CbGpPWpGaD
Midazolam—GABRQ—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000336	0.00559	CbGpPWpGaD
Midazolam—GABRR2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000336	0.00559	CbGpPWpGaD
Midazolam—GABRG2—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000333	0.00554	CbGpPWpGaD
Midazolam—GABRG3—Neuronal System—NEFL—hypothyroidism	0.000332	0.00551	CbGpPWpGaD
Midazolam—GABRB1—Neuronal System—NEFL—hypothyroidism	0.000327	0.00543	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—ATP5O—hypothyroidism	0.000326	0.00541	CbGpPWpGaD
Midazolam—CYP4B1—Biological oxidations—POMC—hypothyroidism	0.000325	0.0054	CbGpPWpGaD
Midazolam—SLC22A1—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.000314	0.00521	CbGpPWpGaD
Midazolam—GABRA6—Neuronal System—NEFL—hypothyroidism	0.000309	0.00514	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—TPO—hypothyroidism	0.000306	0.00509	CbGpPWpGaD
Midazolam—GABRA4—Neuronal System—NEFL—hypothyroidism	0.000305	0.00507	CbGpPWpGaD
Midazolam—SLC22A1—Neuronal System—SLC5A7—hypothyroidism	0.000297	0.00493	CbGpPWpGaD
Midazolam—GABRR1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000292	0.00485	CbGpPWpGaD
Midazolam—GABRA1—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000291	0.00484	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000284	0.00472	CbGpPWpGaD
Midazolam—GABRB2—Neuronal System—NEFL—hypothyroidism	0.000279	0.00464	CbGpPWpGaD
Midazolam—GABRR2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000279	0.00463	CbGpPWpGaD
Midazolam—GABRQ—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000279	0.00463	CbGpPWpGaD
Midazolam—GABRG3—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000277	0.0046	CbGpPWpGaD
Midazolam—GABRB1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000273	0.00453	CbGpPWpGaD
Midazolam—GABRA5—Neuronal System—NEFL—hypothyroidism	0.000271	0.00451	CbGpPWpGaD
Midazolam—GABRA3—Neuronal System—NEFL—hypothyroidism	0.000266	0.00443	CbGpPWpGaD
Midazolam—GABRA2—Neuronal System—NEFL—hypothyroidism	0.000262	0.00435	CbGpPWpGaD
Midazolam—GABRB3—Neuronal System—NEFL—hypothyroidism	0.00026	0.00432	CbGpPWpGaD
Midazolam—SLC22A1—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.00026	0.00432	CbGpPWpGaD
Midazolam—GABRA6—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000258	0.00429	CbGpPWpGaD
Midazolam—GABRG2—Neuronal System—NEFL—hypothyroidism	0.000255	0.00425	CbGpPWpGaD
Midazolam—GABRA4—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000255	0.00423	CbGpPWpGaD
Midazolam—SLC22A1—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000249	0.00414	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—IYD—hypothyroidism	0.00024	0.00398	CbGpPWpGaD
Midazolam—GABRB2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000233	0.00387	CbGpPWpGaD
Midazolam—GABRG3—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000229	0.00381	CbGpPWpGaD
Midazolam—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000228	0.00379	CbGpPWpGaD
Midazolam—GABRA5—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000226	0.00376	CbGpPWpGaD
Midazolam—GABRB1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000226	0.00376	CbGpPWpGaD
Midazolam—GABRB3—BDNF signaling pathway—VAV3—hypothyroidism	0.000224	0.00372	CbGpPWpGaD
Midazolam—GABRA1—Neuronal System—NEFL—hypothyroidism	0.000223	0.00371	CbGpPWpGaD
Midazolam—GABRA3—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000222	0.00369	CbGpPWpGaD
Midazolam—GABRA2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000219	0.00363	CbGpPWpGaD
Midazolam—GABRB3—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000217	0.00361	CbGpPWpGaD
Midazolam—GABRA6—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000214	0.00355	CbGpPWpGaD
Midazolam—GABRG2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000213	0.00354	CbGpPWpGaD
Midazolam—GABRA4—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000211	0.00351	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—ATP5O—hypothyroidism	0.000204	0.00339	CbGpPWpGaD
Midazolam—UGT1A4—Biological oxidations—POMC—hypothyroidism	0.000203	0.00338	CbGpPWpGaD
Midazolam—GABRB2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000193	0.00321	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—TPO—hypothyroidism	0.000192	0.00318	CbGpPWpGaD
Midazolam—SLC22A1—Neuronal System—NEFL—hypothyroidism	0.000191	0.00318	CbGpPWpGaD
Midazolam—GABRA5—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000188	0.00312	CbGpPWpGaD
Midazolam—GABRA1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000186	0.0031	CbGpPWpGaD
Midazolam—CYP3A7—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000185	0.00307	CbGpPWpGaD
Midazolam—GABRA3—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000184	0.00306	CbGpPWpGaD
Midazolam—GABRA2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000181	0.00301	CbGpPWpGaD
Midazolam—GABRB3—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.00018	0.00299	CbGpPWpGaD
Midazolam—GABRG2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000177	0.00294	CbGpPWpGaD
Midazolam—GABRA1—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000174	0.00289	CbGpPWpGaD
Midazolam—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000169	0.0028	CbGpPWpGaD
Midazolam—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000165	0.00274	CbGpPWpGaD
Midazolam—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000165	0.00274	CbGpPWpGaD
Midazolam—SLC22A1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000159	0.00265	CbGpPWpGaD
Midazolam—GABRA1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000154	0.00257	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—TSHB—hypothyroidism	0.000142	0.00236	CbGpPWpGaD
Midazolam—GABRR1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000141	0.00234	CbGpPWpGaD
Midazolam—CYP2B6—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000137	0.00227	CbGpPWpGaD
Midazolam—GABRR2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000134	0.00223	CbGpPWpGaD
Midazolam—GABRQ—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000134	0.00223	CbGpPWpGaD
Midazolam—CYP2E1—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000134	0.00222	CbGpPWpGaD
Midazolam—CYP3A5—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000134	0.00222	CbGpPWpGaD
Midazolam—SLC22A1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000132	0.0022	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—PIK3C2A—hypothyroidism	0.000126	0.0021	CbGpPWpGaD
Midazolam—SLC22A1—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.000125	0.00208	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	0.000125	0.00207	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—IYD—hypothyroidism	0.000116	0.00192	CbGpPWpGaD
Midazolam—GABRR1—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000111	0.00184	CbGpPWpGaD
Midazolam—GABRG3—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000111	0.00184	CbGpPWpGaD
Midazolam—GABRB1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000109	0.00181	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—IYD—hypothyroidism	0.000108	0.00179	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—SLC5A5—hypothyroidism	0.000106	0.00176	CbGpPWpGaD
Midazolam—GABRR2—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000106	0.00176	CbGpPWpGaD
Midazolam—GABRQ—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000106	0.00176	CbGpPWpGaD
Midazolam—GABRA6—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000103	0.00171	CbGpPWpGaD
Midazolam—GABRA4—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000102	0.00169	CbGpPWpGaD
Midazolam—SLC22A1—SLC-mediated transmembrane transport—AVP—hypothyroidism	9.87e-05	0.00164	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—ATP5O—hypothyroidism	9.84e-05	0.00164	CbGpPWpGaD
Midazolam—CYP3A7—Biological oxidations—POMC—hypothyroidism	9.81e-05	0.00163	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	9.35e-05	0.00155	CbGpPWpGaD
Midazolam—GABRB2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	9.32e-05	0.00155	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—TPO—hypothyroidism	9.26e-05	0.00154	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—ATP5O—hypothyroidism	9.16e-05	0.00152	CbGpPWpGaD
Midazolam—GABRA5—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	9.05e-05	0.0015	CbGpPWpGaD
Midazolam—GABRA3—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	8.89e-05	0.00148	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—TSHB—hypothyroidism	8.87e-05	0.00147	CbGpPWpGaD
Midazolam—GABRA2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	8.73e-05	0.00145	CbGpPWpGaD
Midazolam—GABRG3—Transmembrane transport of small molecules—AVP—hypothyroidism	8.71e-05	0.00145	CbGpPWpGaD
Midazolam—GABRB3—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	8.68e-05	0.00144	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—TPO—hypothyroidism	8.61e-05	0.00143	CbGpPWpGaD
Midazolam—GABRB1—Transmembrane transport of small molecules—AVP—hypothyroidism	8.58e-05	0.00143	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—IYD—hypothyroidism	8.56e-05	0.00142	CbGpPWpGaD
Midazolam—GABRG2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	8.52e-05	0.00142	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—IYD—hypothyroidism	8.39e-05	0.00139	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—IYD—hypothyroidism	8.37e-05	0.00139	CbGpPWpGaD
Midazolam—GABRA6—Transmembrane transport of small molecules—AVP—hypothyroidism	8.12e-05	0.00135	CbGpPWpGaD
Midazolam—GABRA4—Transmembrane transport of small molecules—AVP—hypothyroidism	8.02e-05	0.00133	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—PIK3C2A—hypothyroidism	7.91e-05	0.00131	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	7.74e-05	0.00129	CbGpPWpGaD
Midazolam—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	7.66e-05	0.00127	CbGpPWpGaD
Midazolam—GABRA1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	7.45e-05	0.00124	CbGpPWpGaD
Midazolam—GABRB2—Transmembrane transport of small molecules—AVP—hypothyroidism	7.33e-05	0.00122	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—ATP5O—hypothyroidism	7.28e-05	0.00121	CbGpPWpGaD
Midazolam—CYP2B6—Biological oxidations—POMC—hypothyroidism	7.26e-05	0.00121	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—ATP5O—hypothyroidism	7.13e-05	0.00118	CbGpPWpGaD
Midazolam—GABRA5—Transmembrane transport of small molecules—AVP—hypothyroidism	7.13e-05	0.00118	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—ATP5O—hypothyroidism	7.12e-05	0.00118	CbGpPWpGaD
Midazolam—CYP2E1—Biological oxidations—POMC—hypothyroidism	7.11e-05	0.00118	CbGpPWpGaD
Midazolam—CYP3A5—Biological oxidations—POMC—hypothyroidism	7.09e-05	0.00118	CbGpPWpGaD
Midazolam—GABRA3—Transmembrane transport of small molecules—AVP—hypothyroidism	7e-05	0.00116	CbGpPWpGaD
Midazolam—GABRA2—Transmembrane transport of small molecules—AVP—hypothyroidism	6.88e-05	0.00114	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—TPO—hypothyroidism	6.84e-05	0.00114	CbGpPWpGaD
Midazolam—GABRB3—Transmembrane transport of small molecules—AVP—hypothyroidism	6.83e-05	0.00114	CbGpPWpGaD
Midazolam—GABRG2—Transmembrane transport of small molecules—AVP—hypothyroidism	6.71e-05	0.00111	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—TPO—hypothyroidism	6.7e-05	0.00111	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—TPO—hypothyroidism	6.69e-05	0.00111	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—SLC5A5—hypothyroidism	6.64e-05	0.0011	CbGpPWpGaD
Midazolam—SLC22A1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	6.37e-05	0.00106	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—IYD—hypothyroidism	6.31e-05	0.00105	CbGpPWpGaD
Midazolam—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	6.21e-05	0.00103	CbGpPWpGaD
Midazolam—GABRA1—Transmembrane transport of small molecules—AVP—hypothyroidism	5.86e-05	0.000974	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—POMC—hypothyroidism	5.55e-05	0.000923	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—ATP5O—hypothyroidism	5.37e-05	0.000892	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—TPO—hypothyroidism	5.05e-05	0.000839	CbGpPWpGaD
Midazolam—SLC22A1—Transmembrane transport of small molecules—AVP—hypothyroidism	5.02e-05	0.000834	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	4.73e-05	0.000787	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—TSHB—hypothyroidism	4.28e-05	0.000712	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—TSHB—hypothyroidism	3.99e-05	0.000663	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—IYD—hypothyroidism	3.89e-05	0.000646	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PIK3C2A—hypothyroidism	3.82e-05	0.000635	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	3.74e-05	0.000621	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PIK3C2A—hypothyroidism	3.55e-05	0.000591	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—POMC—hypothyroidism	3.47e-05	0.000577	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ATP5O—hypothyroidism	3.31e-05	0.00055	CbGpPWpGaD
Midazolam—CYP3A4—Biological oxidations—POMC—hypothyroidism	3.3e-05	0.000548	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—SLC5A5—hypothyroidism	3.21e-05	0.000533	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—TSHB—hypothyroidism	3.17e-05	0.000527	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—TPO—hypothyroidism	3.11e-05	0.000517	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—TSHB—hypothyroidism	3.1e-05	0.000516	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—TSHB—hypothyroidism	3.1e-05	0.000515	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—SLC5A5—hypothyroidism	2.99e-05	0.000496	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—AVP—hypothyroidism	2.94e-05	0.000489	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PIK3C2A—hypothyroidism	2.82e-05	0.000469	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PIK3C2A—hypothyroidism	2.77e-05	0.00046	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PIK3C2A—hypothyroidism	2.76e-05	0.000459	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—SLC5A5—hypothyroidism	2.37e-05	0.000394	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—TSHB—hypothyroidism	2.34e-05	0.000388	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—SLC5A5—hypothyroidism	2.32e-05	0.000386	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—SLC5A5—hypothyroidism	2.32e-05	0.000385	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PIK3C2A—hypothyroidism	2.08e-05	0.000346	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—SLC5A5—hypothyroidism	1.75e-05	0.000291	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—POMC—hypothyroidism	1.68e-05	0.000279	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—POMC—hypothyroidism	1.56e-05	0.00026	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—TSHB—hypothyroidism	1.44e-05	0.000239	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	1.28e-05	0.000213	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—POMC—hypothyroidism	1.24e-05	0.000206	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—POMC—hypothyroidism	1.22e-05	0.000202	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—POMC—hypothyroidism	1.21e-05	0.000202	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—SLC5A5—hypothyroidism	1.08e-05	0.000179	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—POMC—hypothyroidism	9.15e-06	0.000152	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—POMC—hypothyroidism	5.64e-06	9.37e-05	CbGpPWpGaD
